Field Trip Health Expands Bought Deal To $17.4 Million

As has become a trend within the psychedelics space, Field Trip Health (CSE: FTRP) this morning announced an increase to its bought deal private placement that was originally announced last night. The upsizing was expected, given that the equity had remained halted despite the news being released last night. The financing as a whole has now increased from $15.0 million to $17.4 million.

The financing, which is being lead by Stifel whom is lead underwriter and sole bookrunner, will now see 3.9 million units of the company sold at $4.50 per unit, for gross proceeds of $17.4 million. Units are to consist of one common share and one half warrant of the company, with each full warrant having an exercise price of $5.60 per share for a period of 18 months following the closing of the transaction.

An acceleration clause is also present on the warrant, enabling the company to accelerate the expiry of the warrant should common shares of the company exceed a volume weighted average trading price of $9.00 for a period of ten consecutive trading days.

An over-allotment option has also been granted under the financing, as has become customary of late, with the option enabling the underwriters to expand the financing to a total figure of $20.0 million should it be exercised in full. The option exists for a period of 30 days following the closing of the offering.

Net proceeds from the financing are said to be for working capital and general corporate purposes.

Field Trip Health last traded at $5.00 on the CSE.


Information for this analysis was found via Sedar and Field Trip Health. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

Giant Mining Encounters Native Copper As Hole MHB-34 Hits 563 Metres Depth

Verses Hits Commercialization Stage With Genius AI Platform

Related News

Field Trip Health To Uplist To TSX Next Week

Field Trip Health (CSE: FTRP) is growing up. The company this morning announced that it...

Thursday, June 3, 2021, 08:08:47 AM

Eight Capital Initiates Coverage On Field Trip Health With $10.20 Price Target

Earlier this week, Eight Capital launched coverage on a basket of psychedelic companies. This comes...

Friday, September 17, 2021, 10:59:00 AM

Field Trip Health To Launch Amsterdam Location Focused On Psychedelic Truffles

Field Trip Health (CSE: FTRP) is going to Amsterdam. The company announced this morning that...

Tuesday, November 17, 2020, 08:30:37 AM

Field Trip Health Closes $20.0 Million Bought Deal

Field Trip Health (CSE: FTRP) this morning announced the closing of its bought deal financing,...

Tuesday, January 5, 2021, 10:11:00 AM

Psychedelics: The Eight Capital Primer

Eight Capital recently produced a primer on the psychedelic sector saying that the companies are...

Monday, June 14, 2021, 03:38:00 PM